Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Takeshi Okada, M.D., Ph.D.

Concepts (152)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Takeshi Okada's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Takeshi Okada has written about over time.
Atherosclerosis, 3 publications between 2013 and 2020, average publication date December 2015. Cholesterol Ester Transfer Proteins, 2 publications between 2018 and 2019, average publication date July 2018. Lipid Metabolism, Inborn Errors, 2 publications between 2018 and 2019, average publication date July 2018. Proteomics, 1 publications between 2019 and 2019, average publication date January 2019. Hypolipidemic Agents, 2 publications between 2017 and 2020, average publication date March 2019. Chromatography, Gel, 2 publications between 2018 and 2021, average publication date July 2019. Chromatography, High Pressure Liquid, 2 publications between 2018 and 2021, average publication date July 2019. Hypertriglyceridemia, 2 publications between 2017 and 2022, average publication date November 2019. Lipoproteins, HDL, 2 publications between 2019 and 2020, average publication date November 2019. Lipoproteins, 3 publications between 2018 and 2021, average publication date February 2020. Enzyme-Linked Immunosorbent Assay, 1 publications between 2020 and 2020, average publication date October 2020. Oxidation-Reduction, 1 publications between 2020 and 2020, average publication date October 2020. Dyslipidemias, 2 publications between 2020 and 2021, average publication date December 2020. Hyperlipoproteinemia Type II, 2 publications between 2020 and 2021, average publication date December 2020. Benzoxazoles, 2 publications between 2021 and 2022, average publication date August 2021. Butyrates, 2 publications between 2021 and 2022, average publication date August 2021. Probucol, 2 publications between 2020 and 2023, average publication date December 2021. Ketocholesterols, 2 publications between 2021 and 2022, average publication date January 2022.

To see the data from this visualization as text, click here.
Okada's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (152)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.